Bottom line is....the company is developing a treatment for cervical cancer. the technology is sound, and the phase 2b results were great.
My view is that this should be the driver behind an increased SP.
The anticipation of a NASDAQ listing has clearly overshadowed the promising clinical results.
How unfortunate...share price should be a lot higher. Seriously undervalued stock.
who cares about nasdaq
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.5¢ |
Change
-0.100(23.0%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 40.0¢ | 23.0¢ | $16.23M | 50.19M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 704297 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 102135 | 2 |
View Market Depth
| Last trade - 16.10pm 27/06/2024 (20 minute delay) ? |
| IMM (ASX) Chart |